CHYM vs BLSH
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 15, 2026
CHYM
BLSH
Investment Advisor Scores
BLSH
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CHYM | BLSH | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 26.3852 | 51.0204 | CHYM |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 26.8% | 65.5% | BLSH |
| Earnings Growth | -33.8% | 0.0% | BLSH |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 26.1/100 | 35.4/100 | BLSH |
| Profit Margin | -0.7% | 0.0% | BLSH |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | SELL | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CHYM
MarkupPrice above SMA50, rising 50-day trend (22.3% over 20 days), RSI 72
BLSH
NeutralMixed signals - no dominant trend phase, RSI 67
Fundamentals Snapshot
| Metric | CHYM | BLSH |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 37.1 | 12.0 |
| Trailing P/E | 6.2 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | 0.7% |
| Gross Margin | 0.9% | 1.0% |
| Operating Margin | 0.2% | -3.1% |
| EPS | 5.19 | -10.57 |
| Dividend Yield | — | — |